Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Annette Von Drygalski

    TitleAssociate Clinical Professor
    SchoolUniversity of California, San Diego
    DepartmentMedicine
    Address9500 Gilman Drive #0878
    CA San Diego 92122
    Phone858-657-6028
    vCardDownload vCard
      Other Positions
      TitleDirector, Hemophilia and Thrombosis Treatment Center
      InstitutionUniversity of California, San Diego


      Collapse Biography 
      Collapse Awards and Honors
      San Diego County Medical Society2014Physician of Exceptional Excellence Award in Hematology
      National Hemophilia Foundation/Novo Nordisk2013Career Development Award
      Bayer Healthcare2012Early Career Development Award
      American Society of Hematology2010American Society of Hematology Research Training Fellowship Award

      Collapse Overview 
      Collapse Overview
      Dr. von Drygalski is the Director of the Hemophilia and Thrombosis Treatment Center at UCSD (http://health.ucsd.edu/specialties/hemophilia/Pages/default.aspx) and her research interests involve basic, translational and clinical science in the field of hemostasis and thrombosis, specifically hemophilia.

      Dr. von Drygalski collaborates with Laurent O. Mosnier and John H. Griffin, Ph.D., at The Scripps Research Institute in La Jolla, focusing on the development of novel bypassing treatment strategies, mechanisms of fibrinolysis and joint disease in hemophilia. Dr. von Drygalski maintains a clinical research program studying the aging patient with hemophilia in aspects such as hemophilic arthropathy and the hypertension of hemophilia. She is the primary institutional investigator for several international clinical trials evaluating new treatment options for patients with hemophilia. Dr. von Drygalski was the recent recipient of a National Hemophilia/Novo Nordisk Career Development Award and a Bayer Early Career Development Award.


      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Barnes RF, Cramer TJ, Hughes TH, von Drygalski A. The hypertension of hemophilia is associated with vascular remodeling in the joint. Microcirculation. 2017 Jun 19. PMID: 28627086.
        View in: PubMed
      2. Walsh CE, Workowski K, Terrault NA, Sax PE, Cohen A, Bowlus CL, Kim AY, Hyland RH, Han B, Wang J, Stamm LM, Brainard DM, McHutchison JG, von Drygalski A, Rhame F, Fried MW, Kouides P, Balba G, Reddy KR. Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders. Haemophilia. 2017 Mar; 23(2):198-206. PMID: 28124511.
        View in: PubMed
      3. Barnes RF, Cramer TJ, Sait AS, Kruse-Jarres R, Quon DV, von Drygalski A. The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort Study. Int J Hypertens. 2016; 2016:2014201. PMID: 27965893.
        View in: PubMed
      4. Martin EJ, Cooke EJ, Ceponis A, Barnes RF, Moran CM, Holle S, Hughes TH, Moore RE, von Drygalski A. Efficacy and safety of point-of-care ultrasound-guided intra-articular corticosteroid joint injections in patients with haemophilic arthropathy. Haemophilia. 2017 Jan; 23(1):135-143. PMID: 27486060.
        View in: PubMed
      5. Kidder W, Chang EY, M Moran C, Rose SC, von Drygalski A. Persistent Vascular Remodeling and Leakiness are Important Components of the Pathobiology of Re-bleeding in Hemophilic Joints: Two Informative Cases. Microcirculation. 2016 Jul; 23(5):373-8. PMID: 26833634.
        View in: PubMed
      6. Sun HL, Yang M, Sait AS, von Drygalski A, Jackson S. Haematuria is not a risk factor of hypertension or renal impairment in patients with haemophilia. Haemophilia. 2016 Jul; 22(4):549-55. PMID: 27030081.
        View in: PubMed
      7. Gale AJ, Bhat V, Pellequer JL, Griffin JH, Mosnier LO, Von Drygalski A. Safety, Stability and Pharmacokinetic Properties of (super)Factor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe Bleeding. Pharm Res. 2016 06; 33(6):1517-26. PMID: 26960296; PMCID: PMC4854778 [Available on 06/01/17].
      8. Huang WT, Cang WC, Derry KL, Lane JR, von Drygalski A. Four-Factor Prothrombin Complex Concentrate for Coagulopathy Reversal in Patients With Liver Disease. Clin Appl Thromb Hemost. 2016 Jan 01; 1076029616668406. PMID: 27628534.
        View in: PubMed
      9. Cramer TJ, Anderson K, Navaz K, Brown JM, Mosnier LO, von Drygalski A. Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent male. Blood Cells Mol Dis. 2016 Mar; 57:8-12. PMID: 26852649; PMCID: PMC4874642 [Available on 03/01/17].
      10. Wyseure T, Mosnier LO, von Drygalski A. Advances and challenges in hemophilic arthropathy. Semin Hematol. 2016 Jan; 53(1):10-9. PMID: 26805902; PMCID: PMC5034876 [Available on 01/01/17].
      11. Bhat V, von Drygalski A, Gale AJ, Griffin JH, Mosnier LO. Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa. Thromb Haemost. 2016 Mar; 115(3):551-61. PMID: 26466980; PMCID: PMC4775351 [Available on 02/28/17].
      12. Bhat V, Olmer M, Joshi S, Durden DL, Cramer TJ, Barnes RF, Ball ST, Hughes TH, Silva M, Luck JV, Moore RE, Mosnier LO, von Drygalski A. Vascular remodeling underlies rebleeding in hemophilic arthropathy. Am J Hematol. 2015 Nov; 90(11):1027-35. PMID: 26257191; PMCID: PMC4618067 [Available on 11/01/16].
      13. Kidder W, Nguyen S, Larios J, Bergstrom J, Ceponis A, von Drygalski A. Point-of-care musculoskeletal ultrasound is critical for the diagnosis of hemarthroses, inflammation and soft tissue abnormalities in adult patients with painful haemophilic arthropathy. Haemophilia. 2015 Jul; 21(4):530-7. PMID: 25623830.
        View in: PubMed
      14. von Drygalski A, Bhat V, Gale AJ, Burnier L, Cramer TJ, Griffin JH, Mosnier LO. An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C. PLoS One. 2014; 9(8):e104304. PMID: 25127130; PMCID: PMC4134195.
      15. Sait AS, Kuo A, Bettencourt R, Bergstrom J, Allison M, von Drygalski A. Risk assessment for coronary heart disease in patients with haemophilia: a single centre study in the United States. Haemophilia. 2014 Nov; 20(6):763-70. PMID: 24893625.
        View in: PubMed
      16. von Drygalski A, Cramer TJ, Bhat V, Griffin JH, Gale AJ, Mosnier LO. Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant. J Thromb Haemost. 2014; 12(3):363-72. PMID: 24818532; PMCID: PMC4161283.
      17. Macauley MS, Pfrengle F, Rademacher C, Nycholat CM, Gale AJ, von Drygalski A, Paulson JC. Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis. J Clin Invest. 2013 Jul; 123(7):3074-83. PMID: 23722906; PMCID: PMC3706185.
      18. Ceponis A, Wong-Sefidan I, Glass CS, von Drygalski A. Rapid musculoskeletal ultrasound for painful episodes in adult haemophilia patients. Haemophilia. 2013 Sep; 19(5):790-8. PMID: 23672827.
        View in: PubMed
      19. von Drygalski A, Kolaitis NA, Bettencourt R, Bergstrom J, Kruse-Jarres R, Quon DV, Wassel C, Li MC, Waalen J, Elias DJ, Mosnier LO, Allison M. Prevalence and risk factors for hypertension in hemophilia. Hypertension. 2013 Jul; 62(1):209-15. PMID: 23630949; PMCID: PMC3850775.
      20. von Drygalski A, Furlan-Freguia C, Ruf W, Griffin JH, Mosnier LO. Organ-specific protection against lipopolysaccharide-induced vascular leak is dependent on the endothelial protein C receptor. Arterioscler Thromb Vasc Biol. 2013 Apr; 33(4):769-76. PMID: 23393392; PMCID: PMC3735365.
      21. von Drygalski A, Furlan-Freguia C, Mosnier LO, Yegneswaran S, Ruf W, Griffin JH. Infrared fluorescence for vascular barrier breach in vivo--a novel method for quantitation of albumin efflux. Thromb Haemost. 2012 Nov; 108(5):981-91. PMID: 23052565; PMCID: PMC3597782.
      22. von Drygalski A, Adamson JW. Iron metabolism in man. JPEN J Parenter Enteral Nutr. 2013 Sep; 37(5):599-606. PMID: 22968710.
        View in: PubMed
      23. von Drygalski A, Adamson JW. Ironing out fatigue. Blood. 2011 Sep 22; 118(12):3191-2. PMID: 21940826.
        View in: PubMed
      24. von Drygalski A, Tran TB, Messer K, Pu M, Corringham S, Nelson C, Ball ED. Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support. Int J Breast Cancer. 2011; 2011:523276. PMID: 22295228; PMCID: PMC3262587.
      25. von Drygalski A, Andris DA, Nuttleman PR, Jackson S, Klein J, Wallace JR. Anemia after bariatric surgery cannot be explained by iron deficiency alone: results of a large cohort study. Surg Obes Relat Dis. 2011 Mar-Apr; 7(2):151-6. PMID: 20702143.
        View in: PubMed
      26. von Drygalski A, Andris DA. Anemia after bariatric surgery: more than just iron deficiency. Nutr Clin Pract. 2009 Apr-May; 24(2):217-26. PMID: 19321896.
        View in: PubMed
      27. von Drygalski A, Biller J. Anemia in cystic fibrosis: incidence, mechanisms, and association with pulmonary function and vitamin deficiency. Nutr Clin Pract. 2008 Oct-Nov; 23(5):557-63. PMID: 18849562.
        View in: PubMed
      28. Von Drygalski A, Curtis BR, Bougie DW, McFarland JG, Ahl S, Limbu I, Baker KR, Aster RH. Vancomycin-induced immune thrombocytopenia. N Engl J Med. 2007 Mar 01; 356(9):904-10. PMID: 17329697.
        View in: PubMed
      29. von Drygalski A, Savatski L, Eastwood D, Klein J, Adamson JW. The rate of marrow recovery and extent of donor engraftment following transplantation of ex vivo-expanded bone marrow cells are independently influenced by the cytokines used for expansion. Stem Cells Dev. 2005 Oct; 14(5):564-75. PMID: 16305341.
        View in: PubMed
      30. Von Drygalski A, Alespeiti G, Ren L, Adamson JW. Murine bone marrow cells cultured ex vivo in the presence of multiple cytokine combinations lose radioprotective and long-term engraftment potential. Stem Cells Dev. 2004 Feb; 13(1):101-11. PMID: 15068698.
        View in: PubMed
      31. von Drygalski A, Adamson JW. Placental/umbilical cord blood (PCB) stem cells for transplantation: early clinical outcomes and the status of ex vivo expansion strategies. Keio J Med. 2000 Dec; 49(4):141-51. PMID: 11192982.
        View in: PubMed
      32. von Drygalski A, Ogilvie A. Ecto-diadenosine 5',5'''-P1,P4-tetraphosphate (Ap4A)-hydrolase is expressed as an ectoenzyme in a variety of mammalian and human cells and adds new aspects to the turnover of Ap4A. Biofactors. 2000; 11(3):179-87. PMID: 10875305.
        View in: PubMed
      Annette's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _